Jim Gray
Analyst · Ben Bienvenu from Stephens. You may begin
Thanks Jim. Net sales of $1,349 million were down 13% for the quarter versus prior year. Gross profit margin was 20.1%, down 110 basis points. Reported and adjusted operating incomes were $113 million and $127 million respectively. Reported operating income was lower than adjusted operating income due to asset closures and restructuring costs related to cost mark. Our reported and adjusted earnings per share were $0.98 and $1.12 respectively. Second quarter net sales of $1,349 million were down 13% versus prior year. We experienced negative foreign exchange impacts of $59 million. Sales volume decline of $183 million, primarily driven by COVID-19 impacts around the world was partially offset by $41 million of favorable price/mix. In North America, net sales were down 13% versus prior year, due to sales volume decline of negative 15%. South America net sales were down 19% primarily driven by a negative impact of 18% from foreign exchange. Sales volume decline of 11% was nearly offset by 10 percentage points of favorable price/mix. In Asia-Pacific net sales were down 8% as pressure was felt from foreign currency weakness and sales volume decline. Unfavorable price/mix reflects lower tapioca raw material costs in ASEANI and related pricing to customers. EMEA net sales were down 8% primarily driven by foreign currency weakness in Pakistan. Sales volume declines in Pakistan outweighed the rest of the region, however, the region did deliver strong price mix. For the quarter reported operating income decreased by $55 million, while adjusted operating income decreased by $51 million. The decrease in reported operating income versus adjusted operating income is primarily due to asset closures in our North America potato network and restructuring costs related to Cost Smart. Operating income declined in each region, as Jim referenced earlier. The increase in corporate costs for the quarter was driven by higher legal costs, continued investments to drive innovation and centralization of global business services into corporate. In addition, our company incurred incremental COVID-19 expense for personal protective equipment, sanitization and health screening as well as an interim appreciation pay program at our U.S. manufacturing facilities, which has ended. This direct expense amounted to $7 million during the quarter with the majority incurred in North America. Turning to our earnings bridge. On the left side of the page, you can see the reconciliation from reported to adjusted. On the right side operationally, we saw a decrease of $0.55 per share for the quarter, primarily driven by a volume decline of $0.35 and a margin decrease of $0.09. Unfavorable foreign exchange was an $0.08 impact to the quarter. Moving to our non-operational items. We saw an increase of $0.01 per share for the quarter driven by a favorable tax rate. Financing costs are higher due to realized losses on FX hedges as well as impacts of hyperinflation accounting. Underlying net interest expense was lower versus prior year. Year-to-date net sales of $2,892 millions were down 6% for the first half versus the year ago period. Gross profit margin was 20.5% down 40 basis points. Reported and adjusted operating incomes were $266 million and $294 million respectively. Reported operating income was lower than adjusted operating income due to asset closures and restructuring costs related to Cost Smart. Our reported and adjusted earnings per share were $2.08 and $2.72 respectively. Year-to-date net sales of $2892 million were down $194 million from the same period a year ago. Foreign exchange impacts represented a $100 million headwind. Sales volumes declined of $178 million was partially offset by $84 million of favorable price/mix. The growth product platforms that comprise specialties represent 32% of net sales year-to-date. Excluding foreign exchange impacts net sales of specialty ingredients within the product portfolio were slightly positive year-over-year and we will provide another update regarding specialty ingredients at year-end. Through the first half of 2020 we advanced many initiatives under our Cost Smart savings program to optimize our network and reshape our organization. During the quarter, we completed the consolidation of our potato manufacturing network in the U.S.. Furthermore, we continue to advance the expansion of global business services into the functions of Finance and HR. We are also pursuing opportunities in this new dynamic work environment to reengineer how we work with one another and with our customers. We're confident in our ability to deliver on our 2020 run rate savings target of $90 million to $100 million which is part of our now increased savings target of $170 million by 2021. I'd also highlight that our total company expenses year-to-date are down 1%, despite the additional COVID-19 costs I referenced earlier. Turning to our year-to-date earnings bridge, operationally we saw a decrease of $0.53 per share driven by a volume decline of $0.38 which was slightly offset by margin improvement of $0.02 per share. Unfavorable foreign exchange and other income items represented a negative $0.13 and a negative $0.04 decline per share respectively. Moving to our non-operational items, we saw an increase of $0.06 per share year-to-date driven by a favorable tax rate, lower financing costs and other nonoperating income items. Moving to cash flow, cash provided by operations was $294 million in the first half. Capital expenditures were $175 million, up $19 million from the prior year period due to the timing of payments for our growth projects. During the second quarter, we issued two senior notes aggregating $1 billion in principal and subsequently paid down our revolving credit facility and substantially lowered our future financing costs. At quarter end, we had cash and cash equivalents of $1047 million. Following the quarter's end, we have used cash towards the acquisition of PureCircle and the redemption of our November 2020 senior notes. Moving from cash flow to our balance sheet, we are well positioned with greater financial flexibility due to our strong balance sheet. With solid investment-grade ratings and a debt leverage ratio of 1.8x net debt to adjusted EBITDA for the trailing 12 months, we have sufficient debt capacity and solid creditworthiness to manage through future business cycles. Turning to the third quarter, due to the uncertainty of COVID-19 we cannot reasonably estimate full year results at this time. During the third quarter we expect continued adverse impacts from COVID-19 on net sales across our operating segments with recovery and sales generally correlated with easing of restrictions and increased consumer mobility. For the third quarter, we expect adjusted operating income for the company to be down in the mid-teens versus prior year with the greatest range of potential outcomes in South America. We expect sequential improvement in North America as the U.S. and Mexico demonstrate greater consumer mobility in comparison to the severe shutdowns experienced in quarter two. In Q3 we anticipate South America's operating income change to be similar to quarter two due to the impact of the prevalence of COVID-19 cases, and extended country lockdowns combined with the fact that South America will be at the height of their winter season. Barring a significant second wave of heightened COVID cases, we believe Asia Pacific performance can be down low single digits or better in the third quarter. We anticipate that EMEA demonstrates sequential improvement assuming that Pakistan does not experience continued or severe stay-at-home restrictions. Regarding PureCircle, given the distressed conditions under which it is recently operating, we will be laser-focused on its turnaround for the next 12 months and anticipate mid-single digit operating losses in the near-term as the team works to drive the integration. For Ingredion overall, we anticipate cash flow in line with changes to operating income. For the year, committed capital investments are anticipated to be between $290 million to $310 million. Our reported effective annual tax rate is anticipated to be between 29% and 33%, and our adjusted effective annual tax rate is expected to be between 26% to 27%. With that, let me turn the call back to Jim.